Regis Healthcare Surges on Strong Half-Year Results, Driven by Revenue Growth and Strategic Acquisitions
Melbourne, VIC – Shares in Regis Healthcare Ltd (ASX: REG), a prominent player in Australia’s residential aged care sector, experienced a significant uplift today, outperforming the broader market. The company’s stock closed Friday trading at $6.44. In early Monday morning trade, Regis Healthcare shares were changing hands for $6.86 apiece, marking a robust 6.5% increase. This surge contrasts with the S&P/ASX 300 Index, which saw a more modest 0.2% gain during the same period.
The impressive performance of Regis Healthcare is directly attributed to the release of its compelling half-year earnings results for the first half of the 2026 financial year (H1 FY2026).
S&P/ASX 300 Index
(ASX: XKO)
healthcare
share
Key Financial Highlights Driving the Share Price Increase
Regis Healthcare reported a substantial 18% year-on-year increase in its revenue from services, reaching $667.7 million. This significant growth was underpinned by several key factors, according to management:
- Enhanced AN-ACC Pricing: The Australian National Aged Care Classification (AN-ACC) pricing adjustments contributed positively to the company’s revenue streams.
- Improved Occupancy Rates: Higher occupancy across its facilities played a crucial role in boosting service revenue.
- Strategic Acquisitions: The successful integration of recent acquisitions, including Ti Tree Operations, Rockpool, and OC Health, has been instrumental. These acquisitions have collectively added eight new aged care homes and over 1,000 beds to Regis Healthcare’s national portfolio, expanding its operational footprint and capacity.
Beyond revenue, the company’s profitability also saw positive movement. Underlying earnings before interest, taxes, depreciation, and amortisation (EBITDA) for H1 FY2026 rose by 4% to $70.6 million.
Furthermore, Regis Healthcare demonstrated exceptional strength in its cash flow generation. Net operating cash flow surged by an impressive 40% compared to H1 FY2025, reaching $291.7 million. This substantial increase was largely driven by a significant net inflow of refundable accommodation deposits (RADs) amounting to $178.5 million.
On the bottom line, the company reported an underlying net profit after tax (NPAT) of $29.7 million, which was broadly in line with the previous year’s H1 FY2025 results. However, statutory NPAT was reported at $13.4 million, a 45% decrease year-on-year. This reduction was primarily due to one-off costs associated with the company’s acquisition activities during the six-month period.
Investors seeking passive income were also rewarded, with the board declaring a fully franked interim dividend of 9 cents per share. This represents an 11.1% increase from the previous year’s interim payout, which was only 60% franked.
As of December 31st, Regis Healthcare maintained a healthy net cash position of $198 million, reflecting a 10% year-on-year increase.
Management’s Outlook and Growth Strategy
Linda Mellors, Managing Director and CEO of Regis Healthcare, expressed optimism about the company’s performance and future prospects. She highlighted the resilience and momentum of the business amidst a dynamic operating environment.
“Our half-year results demonstrate the resilience and momentum of the business as we continue to operate in a rapidly evolving operating environment,” Mellors stated. “We remain focused on delivering high-quality care while advancing our growth strategy, supported by high occupancy and continued investment in our people and service offering.”
Looking ahead, Mellors outlined the company’s strategic initiatives and expansion plans:
- New Home Performance: The successful ramp-up of the Camberwell home in its inaugural year has set a positive precedent.
- Greenfield Pipeline: Progress is being made on new greenfield developments, with the Toowong and Carlingford projects currently under construction.
- Strategic Investments: Regis Healthcare continues to invest in strategic initiatives designed to ensure the long-term success of the business.
- Future Growth Opportunities: With an active pipeline of mergers and acquisition (M&A) opportunities and nine greenfield development projects in various stages of planning, Regis is strategically positioned for sustained growth in the years to come.
Should You Consider Investing in Regis Healthcare?
The strong financial performance and clear growth strategy presented by Regis Healthcare offer a compelling case for investors. The company’s ability to navigate a complex industry, expand its operational capacity through strategic acquisitions, and deliver solid returns to shareholders underscores its market position.
As with any investment decision, it is crucial for potential investors to conduct their own thorough research and consider their individual financial goals and risk tolerance. While Regis Healthcare has demonstrated significant positive momentum, understanding the broader market conditions and the company’s specific risk factors is always advisable.
